These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 24260145)
21. Perinatal risk factors interacting with catechol O-methyltransferase and the serotonin transporter gene predict ASD symptoms in children with ADHD. Nijmeijer JS; Hartman CA; Rommelse NN; Altink ME; Buschgens CJ; Fliers EA; Franke B; Minderaa RB; Ormel J; Sergeant JA; Verhulst FC; Buitelaar JK; Hoekstra PJ J Child Psychol Psychiatry; 2010 Nov; 51(11):1242-50. PubMed ID: 20868372 [TBL] [Abstract][Full Text] [Related]
22. Relation of shyness in grade school children to the genotype for the long form of the serotonin transporter promoter region polymorphism. Arbelle S; Benjamin J; Golin M; Kremer I; Belmaker RH; Ebstein RP Am J Psychiatry; 2003 Apr; 160(4):671-6. PubMed ID: 12668354 [TBL] [Abstract][Full Text] [Related]
23. The influence of family structure, the TPH2 G-703T and the 5-HTTLPR serotonergic genes upon affective problems in children aged 10-14 years. Nobile M; Rusconi M; Bellina M; Marino C; Giorda R; Carlet O; Vanzin L; Molteni M; Battaglia M J Child Psychol Psychiatry; 2009 Mar; 50(3):317-25. PubMed ID: 19175813 [TBL] [Abstract][Full Text] [Related]
24. Synergistic effects of COMT and TPH2 on social cognition. Lin CH; Tseng YL; Huang CL; Chang YC; Tsai GE; Lane HY Psychiatry; 2013; 76(3):273-94. PubMed ID: 23965265 [TBL] [Abstract][Full Text] [Related]
25. 5-HTTLPR and COMTval158met genotype gate amygdala reactivity and habituation. Lonsdorf TB; Golkar A; Lindstöm KM; Fransson P; Schalling M; Ohman A; Ingvar M Biol Psychol; 2011 Apr; 87(1):106-12. PubMed ID: 21356267 [TBL] [Abstract][Full Text] [Related]
26. Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT). Benjamin J; Osher Y; Kotler M; Gritsenko I; Nemanov L; Belmaker RH; Ebstein RP Mol Psychiatry; 2000 Jan; 5(1):96-100. PubMed ID: 10673775 [TBL] [Abstract][Full Text] [Related]
27. Temperamental and genetic predictors of suicide attempt and self-mutilation. Dell'osso L; Mandelli L; Carlini M; Bouanani S; Rotondo A; Conversano C; Serretti A; Marazziti D Neuropsychobiology; 2013; 68(4):250-7. PubMed ID: 24280759 [TBL] [Abstract][Full Text] [Related]
28. Genetics of human startle reactivity: A systematic review to acquire targets for an anxiety endophenotype. Tomasi J; Zai CC; Zai G; Kennedy JL; Tiwari AK World J Biol Psychiatry; 2021 Jul; 22(6):399-427. PubMed ID: 33040669 [TBL] [Abstract][Full Text] [Related]
29. Clinical and genetic outcome determinants of Internet- and group-based cognitive behavior therapy for social anxiety disorder. Hedman E; Andersson E; Ljótsson B; Andersson G; Andersson E; Schalling M; Lindefors N; Rück C Acta Psychiatr Scand; 2012 Aug; 126(2):126-36. PubMed ID: 22320999 [TBL] [Abstract][Full Text] [Related]
30. Elevated tph2 mRNA expression in a rat model of chronic anxiety. Donner NC; Johnson PL; Fitz SD; Kellen KE; Shekhar A; Lowry CA Depress Anxiety; 2012 Apr; 29(4):307-19. PubMed ID: 22511363 [TBL] [Abstract][Full Text] [Related]
31. Neural predictors and mechanisms of cognitive behavioral therapy on threat processing in social anxiety disorder. Klumpp H; Fitzgerald DA; Phan KL Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():83-91. PubMed ID: 23665375 [TBL] [Abstract][Full Text] [Related]
32. Interaction between gene variants of the serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT) in borderline personality disorder. Tadić A; Victor A; Başkaya O; von Cube R; Hoch J; Kouti I; Anicker NJ; Höppner W; Lieb K; Dahmen N Am J Med Genet B Neuropsychiatr Genet; 2009 Jun; 150B(4):487-95. PubMed ID: 18756498 [TBL] [Abstract][Full Text] [Related]
33. The therapygenetics of anxiety disorders. Vashishtha S; Kloiber S; Zai G Psychiatr Genet; 2023 Aug; 33(4):123-133. PubMed ID: 37222241 [TBL] [Abstract][Full Text] [Related]
34. 5-HTTLPR and COMT Val158Met are not associated with alexithymia: New evidence and meta-analyses. Yang Y; Li X; Zhao J; Xue M; Zhang M; Wang C; Song H; He L; Guo W; Gong P Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():263-270. PubMed ID: 30707988 [TBL] [Abstract][Full Text] [Related]
35. The impact of the Val158Met catechol-O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives. Lelli-Chiesa G; Kempton MJ; Jogia J; Tatarelli R; Girardi P; Powell J; Collier DA; Frangou S Psychol Med; 2011 Apr; 41(4):779-88. PubMed ID: 20667170 [TBL] [Abstract][Full Text] [Related]
36. Antidepressive-drug-induced bodyweight gain is associated with polymorphisms in genes coding for COMT and TPH1. Secher A; Bukh J; Bock C; Koefoed P; Rasmussen HB; Werge T; Kessing LV; Mellerup E Int Clin Psychopharmacol; 2009 Jul; 24(4):199-203. PubMed ID: 19474754 [TBL] [Abstract][Full Text] [Related]
37. The effect of comorbid major depressive disorder or bipolar disorder on cognitive behavioral therapy for social anxiety disorder. Fracalanza K; McCabe RE; Taylor VH; Antony MM J Affect Disord; 2014 Jun; 162():61-6. PubMed ID: 24767007 [TBL] [Abstract][Full Text] [Related]
38. The effects of child maltreatment on early signs of antisocial behavior: genetic moderation by tryptophan hydroxylase, serotonin transporter, and monoamine oxidase A genes. Cicchetti D; Rogosch FA; Thibodeau EL Dev Psychopathol; 2012 Aug; 24(3):907-28. PubMed ID: 22781862 [TBL] [Abstract][Full Text] [Related]
39. A disorder-specific group cognitive behavior therapy for social anxiety disorder in adolescents: study protocol for a randomized controlled study. Lassen NF; Hougaard E; Arendt KB; Thastum M Trials; 2019 Dec; 20(1):757. PubMed ID: 31864383 [TBL] [Abstract][Full Text] [Related]
40. Cumulative effect of COMT and 5-HTTLPR polymorphisms and their interaction with disease severity and comorbidities on the risk of psychosis in Alzheimer disease. Borroni B; Grassi M; Agosti C; Archetti S; Costanzi C; Cornali C; Caltagirone C; Caimi L; Di Luca M; Padovani A Am J Geriatr Psychiatry; 2006 Apr; 14(4):343-51. PubMed ID: 16582043 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]